A prospective study on inter-operator variability in semi-robotic software-based MRI/TRUS-fusion targeted prostate biopsies

[1] Drost FH(2019)Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer Cochrane Database Syst Rev 4 CD012663-716

[2] Osses DF(2019)A comparison of magnetic resonance imaging techniques used to secure biopsies in prostate cancer patients Expert Rev Anticancer Ther 19 705-928

[3] Nieboer D(2020)MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis N Engl J Med 382 917-298.e299

[4] Steyerberg EW(2019)The added value of systematic biopsy in men with suspicion of prostate cancer undergoing multiparametric MRI-targeted biopsy Urol Oncol 37 298.e291-109

[5] Bangma CH(2019)Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study Lancet Oncol 20 100-1703

[6] Roobol MJ(2019)Intra- and interreader reproducibility of PI-RADSv2: a multireader study J Magn Reson Imaging 49 1694-335

[7] Schoots IG(2019)Defining the target prior to prostate fusion biopsy: the effect of MRI reporting on cancer detection World J Urol 37 327-441

[8] van Luijtelaar A(2017)Changes in prostate cancer detection rate of MRI–TRUS fusion vs systematic biopsy over time: evidence of a learning curve Prostate Cancer Prostatic Dis 20 436-1544

[9] Bomers J(2017)From novice to expert: analyzing the learning curve for MRI-transrectal ultrasonography fusion-guided transrectal prostate biopsy Int Urol Nephrol 49 1537-319

[10] Futterer J(2020)Cancer detection rates and inter-examiner variability of MRI/TRUS fusion targeted biopsy and systematic transrectal biopsy Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 164 314-425

[1] Drost FH(2019)Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer Cochrane Database Syst Rev 4 CD012663-716

[2] Osses DF(2019)A comparison of magnetic resonance imaging techniques used to secure biopsies in prostate cancer patients Expert Rev Anticancer Ther 19 705-928

[3] Nieboer D(2020)MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis N Engl J Med 382 917-298.e299

[4] Steyerberg EW(2019)The added value of systematic biopsy in men with suspicion of prostate cancer undergoing multiparametric MRI-targeted biopsy Urol Oncol 37 298.e291-109

[5] Bangma CH(2019)Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study Lancet Oncol 20 100-1703

[6] Roobol MJ(2019)Intra- and interreader reproducibility of PI-RADSv2: a multireader study J Magn Reson Imaging 49 1694-335

[7] Schoots IG(2019)Defining the target prior to prostate fusion biopsy: the effect of MRI reporting on cancer detection World J Urol 37 327-441

[8] van Luijtelaar A(2017)Changes in prostate cancer detection rate of MRI–TRUS fusion vs systematic biopsy over time: evidence of a learning curve Prostate Cancer Prostatic Dis 20 436-1544

[9] Bomers J(2017)From novice to expert: analyzing the learning curve for MRI-transrectal ultrasonography fusion-guided transrectal prostate biopsy Int Urol Nephrol 49 1537-319

[10] Futterer J(2020)Cancer detection rates and inter-examiner variability of MRI/TRUS fusion targeted biopsy and systematic transrectal biopsy Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 164 314-425